Vanesa Madan - Publications

Affiliations: 
MRC Laboratory of Molecular Biology, Cambridge, England, United Kingdom 

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Dujardin M, Madan V, Gandhi NS, Cantrelle FX, Launay H, Huvent I, Bartenschlager R, Lippens G, Hanoulle X. Cyclophilin A allows the allosteric regulation of a structural motif in the disordered domain 2 of NS5A and thereby fine-tunes HCV RNA replication. The Journal of Biological Chemistry. PMID 31315928 DOI: 10.1074/Jbc.Ra119.009537  0.406
2018 Bednarek S, Madan V, Sikorski PJ, Bartenschlager R, Kowalska J, Jemielity J. mRNAs biotinylated within the 5' cap and protected against decapping: new tools to capture RNA-protein complexes. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 373. PMID 30397103 DOI: 10.1098/Rstb.2018.0167  0.368
2017 Paul D, Madan V, Ramirez O, Bencun M, Stoeck IK, Jirasko V, Bartenschlager R. Glycine-zipper motifs in hepatitis C virus nonstructural protein 4B are required for the establishment of viral replication organelles. Journal of Virology. PMID 29167346 DOI: 10.1128/Jvi.01890-17  0.562
2017 Lougiakis N, Frakolaki E, Karmou P, Pouli N, Marakos P, Madan V, Bartenschlager R, Vassilaki N. Novel nucleoside analogues targeting HCV replication through an NS5A-dependent inhibition mechanism. Chemical Biology & Drug Design. 90: 352-367. PMID 28245093 DOI: 10.1111/Cbdd.12966  0.385
2016 Zayas M, Long G, Madan V, Bartenschlager R. Coordination of Hepatitis C Virus Assembly by Distinct Regulatory Regions in Nonstructural Protein 5A. Plos Pathogens. 12: e1005376. PMID 26727512 DOI: 10.1371/Journal.Ppat.1005376  0.496
2015 Madan V, Bartenschlager R. Structural and Functional Properties of the Hepatitis C Virus p7 Viroporin. Viruses. 7: 4461-81. PMID 26258788 DOI: 10.3390/V7082826  0.386
2015 Redondo N, Madan V, Alvarez E, Carrasco L. Impact of Vesicular Stomatitis Virus M Proteins on Different Cellular Functions. Plos One. 10: e0131137. PMID 26091335 DOI: 10.1371/Journal.Pone.0131137  0.656
2015 Dujardin M, Madan V, Montserret R, Ahuja P, Huvent I, Launay H, Leroy A, Bartenschlager R, Penin F, Lippens G, Hanoulle X. A Proline-Tryptophan Turn in the Intrinsically Disordered Domain 2 of NS5A Protein Is Essential for Hepatitis C Virus RNA Replication. The Journal of Biological Chemistry. 290: 19104-20. PMID 26085105 DOI: 10.1074/Jbc.M115.644419  0.423
2014 Paul D, Madan V, Bartenschlager R. Hepatitis C virus RNA replication and assembly: living on the fat of the land. Cell Host & Microbe. 16: 569-79. PMID 25525790 DOI: 10.1016/J.Chom.2014.10.008  0.463
2014 Madan V, Paul D, Lohmann V, Bartenschlager R. Inhibition of HCV replication by cyclophilin antagonists is linked to replication fitness and occurs by inhibition of membranous web formation. Gastroenterology. 146: 1361-72.e1-9. PMID 24486951 DOI: 10.1053/J.Gastro.2014.01.055  0.436
2012 Sánchez-Martínez S, Madan V, Carrasco L, Nieva JL. Membrane-active peptides derived from picornavirus 2B viroporin. Current Protein & Peptide Science. 13: 632-43. PMID 23131189 DOI: 10.2174/138920312804142165  0.674
2012 Nieva JL, Madan V, Carrasco L. Viroporins: structure and biological functions. Nature Reviews. Microbiology. 10: 563-74. PMID 22751485 DOI: 10.1038/Nrmicro2820  0.724
2011 Alvisi G, Madan V, Bartenschlager R. Hepatitis C virus and host cell lipids: an intimate connection. Rna Biology. 8: 258-69. PMID 21593584 DOI: 10.4161/Rna.8.2.15011  0.468
2010 Yang F, Robotham JM, Grise H, Frausto S, Madan V, Zayas M, Bartenschlager R, Robinson M, Greenstein AE, Nag A, Logan TM, Bienkiewicz E, Tang H. A major determinant of cyclophilin dependence and cyclosporine susceptibility of hepatitis C virus identified by a genetic approach. Plos Pathogens. 6: e1001118. PMID 20886100 DOI: 10.1371/Journal.Ppat.1001118  0.413
2010 Madan V, Redondo N, Carrasco L. Cell permeabilization by poliovirus 2B viroporin triggers bystander permeabilization in neighbouring cells through a mechanism involving gap junctions. Cellular Microbiology. 12: 1144-57. PMID 20331640 DOI: 10.1111/J.1462-5822.2010.01460.X  0.681
2010 Madan V, Sánchez-Martínez S, Carrasco L, Nieva JL. A peptide based on the pore-forming domain of pro-apoptotic poliovirus 2B viroporin targets mitochondria. Biochimica Et Biophysica Acta. 1798: 52-8. PMID 19879236 DOI: 10.1016/J.Bbamem.2009.10.013  0.621
2009 Ciesek S, Steinmann E, Wedemeyer H, Manns MP, Neyts J, Tautz N, Madan V, Bartenschlager R, von Hahn T, Pietschmann T. Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A. Hepatology (Baltimore, Md.). 50: 1638-45. PMID 19821520 DOI: 10.1002/Hep.23281  0.419
2007 Madan V, Sánchez-Martínez S, Vedovato N, Rispoli G, Carrasco L, Nieva JL. Plasma membrane-porating domain in poliovirus 2B protein. A short peptide mimics viroporin activity. Journal of Molecular Biology. 374: 951-64. PMID 17963782 DOI: 10.1016/J.Jmb.2007.09.058  0.661
2007 Molina S, Sanz MA, Madan V, Ventoso I, Castelló A, Carrasco L. Differential inhibition of cellular and Sindbis virus translation by brefeldin A. Virology. 363: 430-6. PMID 17360015 DOI: 10.1016/J.Virol.2007.02.001  0.583
Show low-probability matches.